Amarachi Ejiawoko1, Henry C Lee2, Tianyao Lu3, Joanne Lagatta4. 1. School of Public Health, University of California, Berkeley, CA. 2. Department of Pediatrics, Stanford University, Palo Alto, CA. 3. California Perinatal Quality Care Collaborative, Stanford University, Palo Alto, CA. 4. Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI. Electronic address: jlagatta@mcw.edu.
Abstract
OBJECTIVES: To identify predictors of home oxygen use in preterm infants with bronchopulmonary dysplasia (BPD) in a statewide cohort, identify hospital variation in home oxygen use, and determine the relationship between home oxygen use and neonatal intensive care unit discharge timing. STUDY DESIGN: This was a secondary analysis of California Perinatal Quality Care Collaborative data. Infants were born <32 weeks of gestation, diagnosed with BPD based on respiratory support at 36 weeks postmenstrual age (PMA), and discharged home. Risk factors for home oxygen use were identified using a logistic mixed model with center as random effect. Estimates were used to calculate each center's observed to expected ratio of home oxygen use, and a Spearman coefficient between center median PMA at discharge and observed and expected proportions of home oxygen use. RESULTS: Of 7846, 3672 infants (47%) with BPD were discharged with home oxygen. Higher odds of home oxygen use were seen with antenatal steroids, maternal hypertension, earlier gestational age, male sex, ductus arteriosus ligation, more ventilator days, nitric oxide, discharge from regional hospitals, and PMA at discharge (receiver operating characteristic area under the curve 0.85). Of 92 hospitals, home oxygen use ranged from 7% to 95%; 42% of observed home oxygen use was significantly higher or lower than expected given patient characteristics. The 67 community hospitals with higher observed rates of home oxygen had earlier median PMA at discharge (correlation -0.27, P = .024). CONCLUSIONS: Clinical and hospital factors predict home oxygen use. Home oxygen use varies across California, with community centers using more home oxygen having a shorter length of stay.
OBJECTIVES: To identify predictors of home oxygen use in preterm infants with bronchopulmonary dysplasia (BPD) in a statewide cohort, identify hospital variation in home oxygen use, and determine the relationship between home oxygen use and neonatal intensive care unit discharge timing. STUDY DESIGN: This was a secondary analysis of California Perinatal Quality Care Collaborative data. Infants were born <32 weeks of gestation, diagnosed with BPD based on respiratory support at 36 weeks postmenstrual age (PMA), and discharged home. Risk factors for home oxygen use were identified using a logistic mixed model with center as random effect. Estimates were used to calculate each center's observed to expected ratio of home oxygen use, and a Spearman coefficient between center median PMA at discharge and observed and expected proportions of home oxygen use. RESULTS: Of 7846, 3672 infants (47%) with BPD were discharged with home oxygen. Higher odds of home oxygen use were seen with antenatal steroids, maternal hypertension, earlier gestational age, male sex, ductus arteriosus ligation, more ventilator days, nitric oxide, discharge from regional hospitals, and PMA at discharge (receiver operating characteristic area under the curve 0.85). Of 92 hospitals, home oxygen use ranged from 7% to 95%; 42% of observed home oxygen use was significantly higher or lower than expected given patient characteristics. The 67 community hospitals with higher observed rates of home oxygen had earlier median PMA at discharge (correlation -0.27, P = .024). CONCLUSIONS: Clinical and hospital factors predict home oxygen use. Home oxygen use varies across California, with community centers using more home oxygen having a shorter length of stay.
Authors: Julian Allen; Robert Zwerdling; Richard Ehrenkranz; Claude Gaultier; Robert Geggel; Anne Greenough; Ronald Kleinman; Anne Klijanowicz; Fernando Martinez; Ali Ozdemir; Howard B Panitch; Bruce Nickerson; Martin T Stein; Jean Tomezsko; John Van Der Anker Journal: Am J Respir Crit Care Med Date: 2003-08-01 Impact factor: 21.405
Authors: Richard A Ehrenkranz; Michele C Walsh; Betty R Vohr; Alan H Jobe; Linda L Wright; Avroy A Fanaroff; Lisa A Wrage; Kenneth Poole Journal: Pediatrics Date: 2005-12 Impact factor: 7.124
Authors: J A Lemons; C R Bauer; W Oh; S B Korones; L A Papile; B J Stoll; J Verter; M Temprosa; L L Wright; R A Ehrenkranz; A A Fanaroff; A Stark; W Carlo; J E Tyson; E F Donovan; S Shankaran; D K Stevenson Journal: Pediatrics Date: 2001-01 Impact factor: 7.124
Authors: Avroy A Fanaroff; Barbara J Stoll; Linda L Wright; Waldemar A Carlo; Richard A Ehrenkranz; Ann R Stark; Charles R Bauer; Edward F Donovan; Sheldon B Korones; Abbot R Laptook; James A Lemons; William Oh; Lu-Ann Papile; Seetha Shankaran; David K Stevenson; Jon E Tyson; W Kenneth Poole Journal: Am J Obstet Gynecol Date: 2007-02 Impact factor: 8.661
Authors: Scott A Lorch; Michael Baiocchi; Jeffrey H Silber; Orit Even-Shoshan; Gabriel J Escobar; Dylan S Small Journal: Health Serv Res Date: 2009-09-24 Impact factor: 3.402
Authors: Betty R Vohr; Linda L Wright; Anna M Dusick; Rebecca Perritt; W Kenneth Poole; Jon E Tyson; Jean J Steichen; Charles R Bauer; Deanne E Wilson-Costello; Linda C Mayes Journal: Pediatrics Date: 2004-04 Impact factor: 7.124
Authors: Susan R Hintz; Carla M Bann; Namasivayam Ambalavanan; C Michael Cotten; Abhik Das; Rosemary D Higgins Journal: Pediatrics Date: 2009-12-14 Impact factor: 7.124